ACS report: “Alarming” health disparities in preventable cancers persist as overall cancer mortality continues to fall

In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?

The National Cancer Registries Program, or NPCR, is a relatively small but highly impactful 33-year-old CDC program that gauges disparities in cancer and tracks progress against the disease. So, why was it left out of the Trump administration’s preliminary budget?

April 30, 2025

Vol.51 No.16

Guest Editorial

Regulation must keep up with scientific advances

The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

April 25, 2025

Vol.51 No.16

By Richard M. Goldberg

Cancer Policy

White House preliminary budget document provides no funds for highly impactful CDC cancer registries program

Over the past week, as cancer control experts scoured through a confidential budget document called the “passback” budget, they haven’t been able to find any trace of a relatively small but highly impactful program that funds state cancer registries.

April 25, 2025

Vol.51 No.16

By Paul Goldberg

Conversation with The Cancer Letter

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.

April 04, 2025

Vol.51 No.13

By Paul Goldberg

Building a nationally integrated cancer research and treatment network

Cancer care is at an inflection point. The traditional boundaries between academic and community oncology are dissolving, requiring a reimagined approach to patient care and clinical research. At City of Hope, we are implementing a national model that integrates breakthrough research with accessible, advanced treatment across diverse geographic regions.

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Technological innovations are often hailed as transformative tools capable of revolutionizing healthcare. From gene editing for conditions like sickle cell disease to AI predicting hospital readmissions, to telemedicine expanding healthcare access, these advancements have the potential to change the way we treat diseases.

March 21, 2025

Vol.51 No.11

By Jamillah Hoy-Rosas

ACS report: “Alarming” health disparities in preventable cancers persist as overall cancer mortality continues to fall

YOU MAY BE INTERESTED IN

In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?

Regulation must keep up with scientific advances

White House preliminary budget document provides no funds for highly impactful CDC cancer registries program

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Building a nationally integrated cancer research and treatment network

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Renew today!

Subscriber content

Never miss an issue!

Login